Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,125.00    -5.00 (-0.07%)
Bid:
7,125.00
Ask:
7,130.00
Spread: 5.00 (0.07%)
Market Cap: £9.55b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Q3 Trading Statement

18 Jul 2024 07:00

RNS Number : 8350W
Diploma PLC
18 July 2024
 

10-11 CHARTERHOUSE SQUARE, LONDON EC1M 6EE

TELEPHONE: +44 (0)20 7549 5700

 

18 July 2024

 

STRONG PERFORMANCE CONTINUES

 

 

Diploma PLC ("Diploma" or the "Company"), the international value-add distribution group, today issues a trading update for the nine months ended 30 June 2024.

 

 

· Strong Q3 performance in-line with our expectations: continuing into the final quarter.

 

· Organic revenue growth in year to date of 6%: volume-led growth across the Group with Controls, Seals and Life Sciences performing as expected.

 

· Reported revenue growth in year to date of 13%: with a 10% contribution from acquisitions partly offset by a (3)% impact from foreign exchange.

 

· Smooth onboarding of acquisitions: Peerless and PAR Group acquired into Controls and Seals Sectors in Q3.

 

· Strong operating margin: in line with our expectations.

 

 

Full year outlook positive and unchanged

 

· Constant currency revenue growth of ca. 16%, comprising ca. 6% organic revenue, and growth from acquisitions of ca. 10%

· Strong operating margin of ca. 20.5%

· EPS growth of ca. 15%

· Free cash flow conversion of ca. 90%.

 

 

Johnny Thomson, Chief Executive Officer, and Chris Davies, Chief Financial Officer, will host a conference call for analysts and investors this morning at 8:00am (UK time).

 

Conference call dial in details:

• Dial in: +44 (0) 33 0551 0200

• Password: Diploma Q3 results

 

 

Our next scheduled update is our full year results on 19 November 2024.

 

END

 

 

For further information please contact:

Diploma PLC -

+44 (0)20 7549 5700

Johnny Thomson, Chief Executive Officer

 

Chris Davies, Chief Financial Officer

Holly Gillis, Head of Investor Relations

Teneo -

+44 (0)20 7353 4200

Martin Robinson

Camilla Cunningham

 

 

NOTE TO EDITORS:

 

Diploma PLC is a decentralised, value-add distribution Group. Our businesses deliver practical and innovative solutions that keep key industries moving - from energy and infrastructure to healthcare.

 

We are a distribution group with a difference. Our businesses have the technical expertise, specialist knowledge, and long-term relationships required to deliver value-add products and services that make our customers' lives easier. These value-add solutions drive customer loyalty, market share growth and strong margins.

 

Our decentralised model means our specialist businesses are agile and empowered to deliver the right solutions for their customers, in their own way. As part of Diploma, our businesses can also leverage the additional resources, opportunities and expertise of a large, international and diversified Group to benefit their customers, colleagues, suppliers and communities.

 

We employ c.3,500 colleagues across our three Sectors of Controls, Seals and Life Sciences. Our principal operating businesses are located in the UK, Northern Europe, North America and Australia.

 

Over the last fifteen years, the Group has grown adjusted earnings per share (EPS) at an average of ca. 15% p.a. through a combination of organic growth and acquisitions. Diploma is a member of the FTSE 100.

 

Further information on Diploma PLC can be found at www.diplomaplc.com

 

Diploma hosted an Investor Seminar in June 2023. A recording is available on our website: https://www.diplomaplc.com/investors/results-reports-presentations/investor-seminar-2023/

 

 

The person responsible for releasing this Announcement is John Morrison, Group Company Secretary.

LEI: 2138008OGI7VYG8FGR19

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUBVNRSWUBAAR
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.